Pre-Annual General Meeting Information • Oct 21, 2019
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
If you are in any doubt about what action to take, you should consult your stockbroker, solicitor, accountant or other appropriate independent professional adviser authorised under the Financial Services and Markets Act 2000. If you have sold or otherwise transferred all of your shares in J D Wetherspoon plc (the 'Company'), please forward this document and the accompanying proxy form to the person through whom the sale or transfer was effected, for transmission to the purchaser or transferee.
Dear Shareholder
I am pleased to invite you to our 2019 annual general meeting (the 'Meeting').
The formal notice of Meeting and your proxy form are enclosed.
If you would like to vote on the resolutions, but cannot attend the Meeting, please fill in the proxy form and return it to our registrars at the address detailed in the notes to the notice of Meeting as soon as possible, but in any case by no later than 10am on 19th November 2019. The completion and return of a proxy, or the appointment of a proxy, will not prevent you from attending and voting at the meeting, or any adjournment of it, in person should you wish to do so.
If you plan to attend the Meeting, we also invite you to submit any questions you may want the Company to answer at the Meeting to the address below, for the attention of the Company Secretary, or via e-mail to [email protected] before 10am on 19th November 2019. In addition questions will be invited from the floor of the Meeting itself. It is hoped that advance notice of some of the questions will enable the Company to select important issues to debate which might otherwise be missed. It might also encourage institutional investors to attend.
If you are intending to attend the meeting could you please indicate in the space provided on the proxy form, or by clicking the relevant box if voting electronically.
Please note that the e-mail address above is only to be used for submitting questions in advance for answering at the Meeting and for no other purpose. Any questions received will be answered in accordance with paragraph 10 of the general notes to the notice of meeting.
The directors consider that all resolutions to be put to the Meeting are in the best interests of the Company and its shareholders as a whole. Each of the directors will be voting in favour of each of the resolutions in respect of their own holdings of shares and unanimously recommend that you do so as well.
Yours sincerely
Tim Martin Chairman
Registered office: Wetherspoon House Reeds Crescent Watford WD24 4QL
Registered number: 1709784
Notice is hereby given that the 2019 annual general meeting of J D Wetherspoon plc will be held at The Auditorium, Willis Towers Watson, 51 Lime Street, London, EC3M 7DQ at 10am on 21st November 2019 to consider and, if thought fit, pass the following resolutions.
All resolutions will be proposed as ordinary resolutions, except for resolutions 13, 14 and 15 which will be proposed as special resolutions.
The explanatory notes on pages 5 to 7 give further information on each of the resolutions that are to be proposed at the Meeting.
2
To consider and, if thought fit, pass the following resolutions as ordinary resolutions:
To consider and, if thought fit, pass the following resolutions, in the case of resolution 12 as an ordinary resolution and in the case of resolutions 13, 14 and 15 as special resolutions:
for a period expiring (unless previously revoked, varied or renewed by the Company) on the date which is 15 months from the date of the passing of this resolution or, if sooner, the end of the next annual general meeting of the Company, provided that the Company may, before such expiry, make an offer or agreement which would or might require Relevant Securities to be allotted after this authority expires, and the directors may allot Relevant Securities in pursuance of such offer or agreement, as if this authority had not expired.
This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Act as if, in the first paragraph of this resolution, the words 'pursuant to the authority conferred by resolution 12' were omitted.
By order of the board
Company Secretary
21st October 2019
Wetherspoon House Reeds Crescent Watford WD24 4QL
Save as set out in the explanatory notes to Resolutions 4–10 below, for each resolution that is proposed as an ordinary resolution, more than half of the votes cast in respect of the relevant resolution must be in favour of the resolution for it to be passed. For each of the resolutions that are being proposed as a special resolution, at least three-quarters of the votes cast in respect of the relevant resolution must be in favour of the resolution for it to be passed. Voting on all of the proposed resolutions at the Meeting will be conducted on a poll rather than on a show of hands.
The directors recommend that the Company adopt the reports of the directors and the auditors and the audited accounts of the Company for the year ended 28 July 2019.
Resolution 2, which will be proposed as an ordinary resolution, asks shareholders to approve the directors' remuneration report set out on pages 64 to 67 of the annual report. The vote is advisory in nature and the directors' entitlement to receive remuneration is not conditional on it.
The Company paid an interim dividend of 4.0p per share on 28th May 2019. The directors recommend a final dividend of 8.0p per share, bringing the total dividend for the year ended 28 July 2019 to 12.0p per share. Subject to approval of the proposed dividend by shareholders, the final dividend will be paid on 28 November 2019 to shareholders on the register at close of business on 25 October 2019.
In accordance with the UK Corporate Governance Code (the 'Code'), all of the directors of the Company will stand for re-election to the board. Their biographical details are set out on page 55 of the annual report. The chairman confirms that each director's performance continues to be effective and demonstrates commitment to his or her respective roles, including time commitments for board and committee meetings.
For purposes of the UKLA Listing Rules (the 'Listing Rules'), Tim Martin together with his concert parties (the 'Concert Party'), are together regarded as a controlling shareholder of the Company as a result of them holding in aggregate more than 30% of the ordinary shares in the Company as at 14 October 2019 (being the last practicable date prior to the publication of this document)
As a Company with a controlling shareholder, the Listing Rules require that the appointment of independent non-executive directors must be approved by the majority of both: (i) the shareholders of the Company; and (ii) the independent shareholders of the Company (that is the shareholders other than the Concert Party). Resolutions 8 to 10 relate to the re-appointment of Debra van Gene, Sir Richard Beckett and Harry Morley, who are the directors that the board has determined are independent directors for the purposes of the Code. These resolutions are being proposed as ordinary resolutions which all shareholders may vote on; however, in addition to this, the votes cast by independent
5
shareholders will be counted separately in order to determine whether the second limb of the test is satisfied. Such resolutions will be passed only if they are passed both with and without taking into account the votes of the Concert Party.
The Listing Rules also require a company with a controlling shareholder to disclose information regarding each independent director's relationships and transactions, independence, effectiveness and selection:
Relationships and transactions: The board has received confirmation from each of the independent directors that, other than their respective letters of appointment as directors of the Company, there are no existing or previous relationships, transactions or arrangements between any of the independent directors and the Company, its directors, the Concert Party or any associate of the Concert Party.
Effectiveness: As noted above, the chairman confirms that each independent director's performance continues to be effective and demonstrates commitment to his or her respective roles, including time commitments for board and committee meetings.
Independence: The board believes that each independent director remains independent and that there are no relationships or circumstances that are likely to affect, or appear to affect, his or her judgment. In considering the independence on the non-executive directors, the board has taken into account guidance from the Code.
Selection: The nomination committee meets at least annually and considers, among other matters, board appointments and the re-election of directors. No director is involved in any decision about his or her own re-appointment. In carrying out these activities, the nomination committee follows the guidelines of the Institute of Chartered Secretaries and Administrators and complies with the Code.
Succession planning: The Company has discussed succession plans for its non-executive directors with more than nine years' service with a number of its shareholders. The Company plans to:
appoint a non-executive director in the near future. Elizabeth McMeikan resigned on 8 October 2019. A further announcement will be made in due course regarding the appointment of a senior independent director.
appoint, in due course, a non-executive director to replace Debra van Gene, who will stand down at the Annual General Meeting in November 2021.
appoint a non-executive director to replace Sir Richard Beckett, who will stand down at the Annual General Meeting in November 2022.
The auditors of the Company must be appointed at each general meeting at which accounts are laid to hold office until the conclusion of the next such meeting. The Company proposes Grant Thornton LLP be re-appointed as the Company's auditors for the next financial year and that its directors authorise its remuneration.
The Companies Act 2006 (the 'Act') prevents directors of a public company from allotting shares, other than pursuant to an employee share scheme, without the authority of shareholders in a general meeting. In certain circumstances, this could be unduly restrictive. The general authority previously given to the directors to allot 'relevant securities' will expire at the end of the Meeting.
Accordingly, Resolution 12, which will be proposed as an ordinary resolution, authorises the directors (pursuant to section 551 of the Act) to allot ordinary shares:
(A) up to an aggregate nominal amount of £697,856, representing approximately one-third of the nominal value of the ordinary shares in issue as at 14th October 2019 (being the last practicable date prior to the publication of this document); and
(B) up to a further aggregate nominal amount of £697,856, representing approximately an additional one-third of the nominal value of the ordinary shares in issue as at 14th October 2019 (being the last practicable date prior to the publication of this document), provided that they are offered by way of a rights issue in favour of ordinary shareholders.
The Company does not currently hold any ordinary shares in treasury.
The authority sought by this resolution (unless previously varied, revoked or renewed) will expire on the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
In accordance with the ABI's best practice guidelines, the limit on the directors' authority to allot shares under section 551 of the Act may be increased from one-third to two-thirds of the Company's issued share capital, provided that the amount of any authority above one-third must be applied to fully pre-emptive rights issues and should be valid for one year only. If the Company makes an allotment pursuant to such additional authority, the ABI will expect that all directors will stand for re-election at the next annual general meeting of the Company following the decision to make the allotment in question.
6
The directors will exercise such authority to allot shares only when satisfied that it is in the interests of the Company to do so. They have no present intention of exercising the authority.
The provisions of section 561 of the Act (which confer on shareholders rights of pre-emption in respect of the allotment of 'equity securities' which are, or are to be, paid up in cash, other than by way of allotment to employees under an employee share scheme) apply to the unissued ordinary shares of the Company to the extent that they are not disapplied, pursuant to sections 570 and 573 of the Act.
The current disapplication of these statutory pre-emption rights will expire at the end of the Meeting. Accordingly, Resolution 13, which will be proposed as a special resolution, permits the directors to allot shares without the application of these statutory pre-emption rights: first, in relation to offers of equity securities by way of rights issue, open offer or similar arrangements (save that, in the case of an allotment pursuant to the authority in paragraph (B) of Resolution 12, such allotment shall be by way of rights issue only); and second, in relation to the allotment of equity securities for cash, up to a maximum aggregate nominal amount of £104,678 (representing approximately 5.00% of the nominal value of the ordinary shares of the Company in issue as at 14th October 2019 (being the last practicable date prior to the publication of this document)).
The authority (unless previously varied, revoked or renewed) will expire on the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
In common with many other listed companies, the Company proposes, once again, to seek an authority from shareholders to permit it to purchase its own shares. Accordingly, Resolution 14 will be proposed as a special resolution to authorise the Company to make market purchases of up to 15,701,759 shares, just under 15% of the Company's current issued ordinary share capital, at prices not less than the nominal value of an ordinary share and not exceeding 105% of the average of the middle-market quotations for an ordinary share for the five business days before each purchase (in each case, exclusive of expenses). The authority will last until the earlier of 15 months from the date of passing the resolution and the conclusion of the next annual general meeting of the Company.
The directors envisage that purchases would be made only after considering the effects on earnings per share and the benefits for shareholders generally.
If Resolution 14 is passed, it is the Company's current intention to cancel all of the shares it may purchase pursuant to the authority granted to it. However, in order to respond properly to the Company's capital requirements and the prevailing market conditions, the board will need to assess at the time of any and each actual purchase whether to hold the shares in treasury or to cancel them, provided it is permitted to do so.
The notice period required for general meetings of the Company to 21 clear days, unless shareholders approve a shorter notice period, which cannot, however, be fewer than 14 clear days. Resolution 15 seeks such approval. The approval will be effective until the Company's next annual general meeting, when it is intended that a similar resolution will be proposed.
In addition, in order to be able to call a general meeting on under 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders at that meeting.
The shorter notice period would not be used as a matter of routine for such meetings, but only where the flexibility is merited by the business of the meeting and is thought to be to the advantage of shareholders as a whole.
Annual general meetings will continue to be held on at least 21 clear days' notice.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.